Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
DITEVAKSAL-T
- Development stage
- Unknown
- Lead developer
- Institute Torlak
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
DITEVAKSAL-T is an adsorbed bivalent vaccine containing purified and concentrated diphtheria and tetanus toxoids. Developed and manufactured by the Institute of Virology, Vaccines and Sera Torlak in Belgrade, Serbia, it is specifically indicated for the active immunization (both primary and booster) of children aged 2 months to 7 years against diphtheria and tetanus. The vaccine works by stimulating the immune system to produce protective antitoxin antibodies against the toxins produced by *Corynebacterium diphtheriae* and *Clostridium tetani*. The toxoids are adsorbed onto an aluminum-based adjuvant to enhance the immune response. It is administered via intramuscular injection and requires cold chain storage at 2-8°C.
- Brand names
- DITEVAKSAL-T
- Other names
- Tetanus and diphtheria vaccine (adsorbed)Diphtheria and tetanus toxoids vaccineDITEVAKSAL-T adsorbed vaccine
02
Targets
Diphtheria toxin
Beyond the preview
Go deeper on DITEVAKSAL-T.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on DITEVAKSAL-T.